Clinical trial
Effect of Betablocker or Aldosterone Antagonist Therapy on Patients With Liver…
NCT00332904 · Hvidovre University Hospital, Other · Unknown status
Key facts
| NCT number | NCT00332904 |
|---|---|
| Title | Effect of Betablocker or Aldosterone Antagonist Therapy on Patients With Liver Cirrhosis |
| Official title | Effect of Betablocker or Aldosterone Antagonist Therapy on Oxygenation, Peripheral and Cardiac Hemodynamics and Humoral Systems |
| Acronym | PEKASYS |
| Lead sponsor | Hvidovre University Hospital, Other |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Liver Cirrhosis, Portal Hypertension |
| Intervention type | Drug |
| Interventions | propranolol, spironolactone |
| Enrollment | 22 |
| Start date | Aug 1, 2006 |
| Primary completion | Jul 1, 2008 |
| Completion | Dec 1, 2010 |
| First posted | Jun 2, 2006 |
| Last update posted | Jun 4, 2010 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: